Study Eases Concern That Common Diabetes Drug Canagliflozin (Invokana, Invokamet) Might Harm Bones
THURSDAY, Jan. 3, 2019 -- If you have type 2 diabetes and you ' re taking canagliflozin to help control your blood sugar, a new study has some good news for you: The drug doesn ' t appear to raise the risk of bone fractures.
Previously, research had...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
More News: Canagliflozin | Diabetes | Diabetes Type 2 | Endocrinology | General Medicine | Invokana | Orthopaedics | Study | Sugar